Patents by Inventor Saori Kunii

Saori Kunii has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells
    Patent number: 11951231
    Abstract: A therapeutic agent for intervertebral disc degeneration that contains LASCol obtained by enzymatically cleaving a terminus of collagen.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: April 9, 2024
    Assignee: KINKI UNIVERSITY
    Inventors: Takashi Yurube, Yoshiki Takeoka, Koichi Morimoto, Saori Kunii, Kaoru Omae
  • COLLAGEN SOLID, METHOD FOR PRODUCING COLLAGEN SOLID, BIOMATERIAL, AND EX VIVO MATERIAL
    Publication number: 20220023499
    Abstract: The present invention provides a collagen solid having higher strength and density. A collagen solid is used which contains a collagen-cysteine protease degradation product or an atelocollagen-cysteine protease degradation product and has a density of 50 mg/cm3 or more.
    Type: Application
    Filed: December 12, 2019
    Publication date: January 27, 2022
    Inventors: Koichi Morimoto, Saori Kunii, Naomasa Fukase, Ryosuke Kuroda, Toshiyuki Takemori
  • THERAPEUTIC AGENT FOR INTERVERTEBRAL DISC DEGENERATION AND MATERIAL FOR CULTURING INTERVERTEBRAL DISC CELLS
    Publication number: 20210046214
    Abstract: A therapeutic agent for intervertebral disc degeneration that contains LASCol obtained by enzymatically cleaving a terminus of collagen.
    Type: Application
    Filed: January 31, 2019
    Publication date: February 18, 2021
    Applicants: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, KINKI UNIVERSITY, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
    Inventors: Takashi YURUBE, Yoshiki TAKEOKA, Koichi MORIMOTO, Saori KUNII, Kaoru OMAE
  • NERVE CELL CULTURE MATERIAL AND THERAPEUTIC AGENT FOR NERVE DAMAGE
    Publication number: 20210047385
    Abstract: A nerve cell culture material including LASCol has the effect of successfully maintaining survival of the nerve cell. Furthermore, a therapeutic agent for nerve damage including LASCol can allow an endogenous nerve cell to infiltrate or proliferate actively in vivo, thereby enabling neurites to extend early and bind to each other, and has an effect on nerve damage, the effect being sufficient to improve a BBB score.
    Type: Application
    Filed: January 31, 2019
    Publication date: February 18, 2021
    Applicants: KINKI UNIVERSITY, AINO UNIVERSITY, FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
    Inventors: Koichi MORIMOTO, Saori KUNII, Kenji KANEKIYO, Norihiko NAKANO, Chizuka IDE, Kaoru OMAE
  • Composition for inducing differentiation
    Patent number: 10155804
    Abstract: To provide a differentiation-inducing composition and a method for producing the differentiation-inducing composition, the present disclosure describes use of a degradation product containing at least a portion of the triple helical domain of collagen or atelocollagen.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: December 18, 2018
    Assignee: Kinki University
    Inventors: Koichi Morimoto, Saori Kunii, Ei Yamamoto, Hiroyuki Ito, Yoshinori Kuboki
  • COMPOSITION FOR INDUCING DIFFERENTIATION
    Publication number: 20170051043
    Abstract: To provide a differentiation-inducing composition and a method for producing the differentiation-inducing composition, the present disclosure describes use of a degradation product containing at least a portion of the triple helical domain of collagen or atelocollagen.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Inventors: Koichi Morimoto, Saori Kunii, Ei Yamamoto, Hiroyuki Ito, Yoshinori Kuboki